• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

Neration measurement in clotting plasma. Pathophysiol Haemost Thromb 2003, 33(1):4?5. 14. Opstad TB, Pettersen AA, Weiss T, Arnesen H, Seljeflot I: Gender differences of polymorphisms in the TF and TFPI genes, as related to phenotypes in patients with coronary heart disease and type-2 diabetes. Thromb J 2010, 8:7. 15. Cadroy Y, Pierrejean D, Fontan B, Sie P, Boneu B: Influence of aging on the activity of the hemostatic system: prothrombin fragment 1 + 2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years. Nouv Rev Fr Hematol 1992, 34(1):43?6. 16. Lowe GD, Rumley A, Woodward M, Morrison CE, Philippou H, Lane DA, et al: Epidemiology of coagulation factors, inhibitors and activation17.18.19.20.21.22. 23. 24.25. 26.27. PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/744568 28. 29.30. 31.32.33.34. 35.36.37.38.39.40.markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol 1997, 97(4):775?84. Haidl H, Cimenti C, Leschnik B, Zach D, Muntean W: Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost 2006, 95(5):772?75. van Hylckama Vlieg1, Christiansen SC, Luddington R, Cannegieter SC, Rosendaal FR, Baglin TP: Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk Phenyl (4-chloro-3-fluorophenyl)carbamate of recurrence. Br J Haematol 2007, 138(6):769?74. Ossei-Gerning N, Wilson IJ, Grant PJ: Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. Thromb Haemost 1998, 79(4):736?40. Stevenson JC, Crook D, Godsland IF: Influence of age and menopause on serum lipids and lipoproteins in healthy women. Atherosclerosis 1993, 98(1):83?0. Caponnetto P, Russo C, Di MA, Morjaria JB, Barton S, Guarino F, et al: Circulating endothelial-coagulative activation markers after smoking cessation: a 12-month observational study. Eur J Clin Invest 2011, 41(6):616?26. Cacciola RR, Guarino F, Polosa R: Relevance of endothelial-haemostatic dysfunction in cigarette smoking. Curr Med Chem 2007, 14(17):1887?892. Kimura S, Nishinaga M, Ozawa T, Shimada K: Thrombin generation as an acute effect of cigarette smoking. Am Heart J 1994, 128(1):7?1. Celi A, Cianchetti S, Dell'Omo G, Pedrinelli R: Angiotensin II, tissue factor and the thrombotic paradox of hypertension. Expert Rev Cardiovasc Ther 2010, 8(12):1723?729. Grant PJ: Diabetes mellitus as a prothrombotic condition. J Intern Med 2007, 262(2):157?72. Koh KK, Quon MJ, Waclawiw MA: Are statins effective Ethyl (4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbamate hydrochloride for simultaneously treating dyslipidemias and hypertension? Atherosclerosis 2008, 196(1):1?. Vijayaraghavan K, Deedwania P: Renin-angiotensin-aldosterone blockade for cardiovascular disease prevention. Cardiol Clin 2011, 29(1):137?56. Brown NJ, Vaughan DE: Prothrombotic effects of angiotensin. Adv Intern Med 2000, 45:419?29. Celi A, Del FA, Cianchetti S, Pedrinelli R: Tissue factor modulation by Angiotensin PubMed ID:https://www.ncbi.nlm.nih.gov/pubmed/10811056 II: a clue to a better understanding of the cardiovascular effects of renin-angiotensin system blockade? Endocr Metab Immune Disord Drug Targets 2008, 8(4):308?13. Vaughan DE: The renin-angiotensin system and fibrinolysis. Am J Cardiol 1997, 79(5A):12?6. Sechi LA, Novello M, Colussi G, Di FA, Chiuch A, Nadalini E, et al: Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. Am J Hypertens 2008, 21(12):1347?353. CAPRIE Steering Committee: A randomised, blinded, trial of clopidogrel versu.